 WALTHAM, Mass., Sept. 22, 2022 GLOBE NEWSWIRE -- Checkpoint Therapeutics, Inc. Checkpoint NASDAQ: CKPT, a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in two upcoming investor conferences. Details are as follows: 